Sleep Apnea Syndrome, Obstructive
Conditions
Keywords
New medical device, Mandibular movement, Respiratory event index, Polysomnography
Brief summary
Sleep Apnea Syndrome (SAS) is a serious health issue that should be managed in order to limit its adverse health consequences. SAS is known to induce cardiovascular diseases, diabetes and depression. The prevalence of SAS is still growing with social and economic repercussion. Today, polysomnography (PSG) is the gold standard reference method for SAS diagnosis. However, it is a constraining and expensive technology. In order to improve patients' life quality, many new technologies have been developed for the SAS diagnosis. The aim of this study is to evaluate the Sunrise®, a new medical integrated solution for SAS diagnosis, in comparison with PSG. This solution consists in a chin sensor recording mandibular movements and measuring the respiratory event index (ERI) through an artificial intelligence algorithm analysis.
Detailed description
Sunrise® is a type IIa medical device with the CE label. It is a new home sleep technology, non-invasive, reliable and affordable by the patient. The objective of this study is to evaluate the efficiency of the device in comparison with PSG for sleep apnea diagnosis. 40 subjects, suspected to be apneic, will be equipped at home by the chin sensor, the Sunrise® device, recording their mandibular movements while sleeping. The Sunrise® solution will provide the respiratory event index (REI) as well as the respiratory micro-arousals. Inclusion visit will be executed at the University Hospital Grenoble Alpes. However, PSG and Sunrise® will be set at the patient's home by IC@dom. The first night, the patient will be equipped by both PSG and Sunrise® and only by the Sunrise® for the two following nights.
Interventions
DIAGNOSTIC_TESTSunrise® solution
Type II medical device with the CE label. It is a chin sensor associated to an integrated and connected platform.
DIAGNOSTIC_TESTPolysomnography
Gold standard method to diagnose SAS used as comparator
Sponsors
Sunrise
Icadom
DOCAPOST
University Hospital, Grenoble
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patients suspected to have a sleep apnea syndrome (Berlin score≥2) * Able to use a smartphone application * Be legally able to give consent * Person affiliated to social security
Exclusion criteria
* Patients already treated for SAS * Patients suffering from a chronic obstructive or restrictive pulmonary disease with or without oxygen. * Patients suffering from a unstable cardiovascular disease or a severe heart failure requiring an hospitalzation in the previous three months or conform with the New York Heart Association criteria for class II or III diseases * Patients treated with myorelaxant medicines * Patients with a long beard disabling the setting of the mandibular sensor * Subjects listed in articles L1121-5 à L1121-8: Pregnant women, feeding and parturient; subject under administrative or judicial control, persons who are protected under the act. * Person in exclusion period for another study or participating in a medical study testing drugs. * Subjects not being cooperative or respecting the study instructions, according the investigator.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The performance of Sunrise® to detect the respiratory event index (REI) | 1 night | Evaluation of the correlation between Sunrise® and PSG for the estimation of the REI |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Evaluation of the Sunrise® reproductibility on three consecutive nights | 3 nights | REI measured by Sunrise® on three consecutive nights |
| Evaluation of the sleep quality: depth of sleep | 3 nights | Depth of sleep was assessed by the St Mary Hospital Questionnaire Q1 (scale from 1 very light to 8 very depth), after one night without device, one night with PSG+Sunrise® and one night with Sunrise® only |
| Evaluation of the sleep quality: number of wake-ups | 3 nights | Number of Wake-ups was assessed by the St Mary Hospital Questionnaire Q2 (scale from 0 no Wake-up to 7 more than 6 Wake-ups), after one night without device, one night with PSG+Sunrise® and one night with Sunrise® only |
| Evaluation of the sleep quality: sleep duration | 3 nights | Sleep duration was assessed by the St Mary Hospital Questionnaire Q3 (in hour), after one night without device, one night with PSG+Sunrise® and one night with Sunrise® only |
Countries
France
Outcome results
None listed